Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Anthrax and supplements

This article was originally published in The Tan Sheet

Executive Summary

FDA issues brief caution against supplements indicated for anthrax prevention, treatment in statement posted on CFSAN Web site Nov. 7. "At this time, there is no credible scientific evidence to suggest that dietary supplements on the market will prevent or treat anthrax," agency says. "Consult your physician at once if you believe you need to be treated for anthrax." Statement directs parties to FTC "consumer alert" for more information (1"The Tan Sheet" Nov. 5, p. 3). AHPA, CHPA, CRN, NNFA, UNPA reinforce similar message in Nov. 5 joint declaration...

You may also be interested in...

FDA, FTC, 30 State AGs Join Forces To Combat Fraudulent Anthrax Products

The Federal Trade Commission is renewing efforts to track down colloidal silver supplements sold online under a federal and state multi-agency campaign against fraudulent products indicated for anthrax

Germany's OTC Market in 2019: Stagnation Overall, Online Growth Continues

A weak cough and cold season in Germany last winter held back OTC sales growth in 2019, according to IQVIA, while the country's online pharmacy channel continued to expand. 

Stockwatch: Choppy Waters For Teva And Bausch

After most of the big pharmaceutical companies reported their full-year 2019 financial results, the second month of earnings season brings the long tail of smaller biotech companies and the generic pharmaceutical companies. There is more than one uncomfortable parallel from the former in the reports of the latter.







Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts